Anti-leukemic activity of Newcastle disease virus strains AF2240 and V4-UPM in murine myelomonocytic leukemia in vivo

Leukemia Research

Volumn 36, Issue 5, 2012, Pages 634-645

  Alabsi, Aied M ^a,b   Ali, Rola ^a   Ideris, Aini ^b   Omar, Abdul Rahman ^b   Bejo, Mohd Hair ^b   Yusoff, Khatijah ^b   Ali, Abdul Manaf ^a  

^a UNIVERSITI SULTAN ZAINAL ABIDIN   (Malaysia)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Apoptosis; BALB c mice; Cytotoxicity; Leukemia; NDV AF2240; NDV V4 UPM

Indexed keywords

CASPASE 3; CYTARABINE; ONCOLYTIC VIRUS;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLAST CELL; CANCER CELL DESTRUCTION; CANCER MORPHOLOGY; CELL POPULATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVATION; FEMALE; HISTOPATHOLOGY; IN VIVO STUDY; LIVER WEIGHT; MALE; MOUSE; MYELOMONOCYTIC LEUKEMIA; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; ONCOLYTIC VIROTHERAPY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPLEEN WEIGHT; VIRUS STRAIN; WEIGHT REDUCTION;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CHICK EMBRYO; HUMANS; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; LIVER; MICE; MICE, INBRED BALB C; NEWCASTLE DISEASE VIRUS; ONCOLYTIC VIROTHERAPY; SPLEEN;

EID: 84858752959     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.11.001     Document Type: Article

References (39)

1. Howard M.R., Hamilton P.J. Haematology: an illustrated colour text 1997, Churchill Livingstone Pearson Professional Limited, New York, USA, p. 10-20. 1st ed.
2. Lee S.J., Kim K.H., Park J.S., Jung J.W., Kim Y.H., Kim S.K., et al. Comparative analysis of cell surface proteins in chronic and acute leukemia cell lines. Biochem Biophys Res Commun 2007, 357:620-626.
3. Yazan LS. Cytotoxic properties of anthraquinones (nordamnacanthal and damnacanthal) from roots of Morinda Elliptica. PhD Thesis, Universiti Putra Malaysia, Malaysia; 2003.
4. Sinkovics J.G., Horvath J. Newcastle disease virus (NDV): brief history of its oncolytic strains. J Clin Virol 2000, 16:1-15.
5. Norman K.L., Farassati F., Lee P.W.K. Oncolytic virus and cancer therapy. Cytokine Growth Factor Rev 2001, 12:271-282.
6. Kirn D., Niculescu-Duvaz I., Hallden G., Springer G.J. The emerging fields of suicide gene therapy and virotherapy. Trends Mol Med 2002, 8:68-73.
7. Ring C.J.A. Cytolytic viruses as potential anti-cancer agents. J Gen Virol 2002, 83:491-502.
8. Bell J.C., Lichty B., Stojdl D. Getting oncolytic virus therapies off the ground. Cancer Cell 2003, 4:7-11.
9. Parato K.A., Senger D., Forsyth P.A.J., Bell J.C. Recent progress in the battle between oncolytic viruses and tumours. Nature 2005, 5:965-976.
10. Nelson N.J. Scientific interest in Newcastle disease virus is reviving. J Natl Cancer Inst 1999, 91:1708-1710.
11. Csatary L.K., Eckhardt S., Bukosza I., Czeg1ed F., Fenyvesi C., Gergely P., Bodey B., Csatary C.M. Attenuated veterinary vaccine for the treatment of cancer. Cancer Detect Prey 1993, 17:619-627.
12. Kirn D.H., McCormick F. Replicating viruses as selective cancer therapeutics. Mol Med Today 1996, 2:519-527.
13. Seal B.S., King D.J., Sellers H.S. The avian response to Newcastle disease virus. Dev Comp Immunol 2000, 24:257-268.
14. Omar A., Aini I., Ali A., Othman F., Yusoff K., Abdullah J.M., Wali H., Zawawi M., Meyyappan N. An overview on the development of Newcastle disease virus as an anti-cancer therapy. Malays J Med Sci 2003, 10:4-12.
15. Warner N.L., Moore M.A., Metcalf D. A transplantable myelomonocytic leukemia in BALB-c mice: cytology, karyotype, and muramidase content. J Natl Cancer Inst 1969, 43:963-982.
16. Hayashi M., Tomida M., Hozumi M. Detection of in vivo differentiation of murine WEHI-3B D+ leukemia cells transfected with the lac-z marker gene using two-color flow cytometry. Leuk Res 1996, 2:333-341.
17. Zulkifli M.M., Ibrahim R., Ali A.M., Aini I., Jaafar H., Hilda S.S., Alitheen N.B., Abdullah J.M. Newcastle diseases virus strain V4UPM displayed oncolytic ability against experimental human malignant glioma. Neurol Res 2009, 13:3-10.
18. Othman F., Ideris A., Motalleb G., Eshak Z.B., Rahmat A. Oncolytic effect of Newcastle disease virus AF2240 strain on the MCF-7 breast cancer cell line. Yakhteh Med J 2010, 12:17-24.
19. Rola A., Aied A.M., Ali A.M., Ideris A., Omar A.R., Yousoff K. Apoptosis induction and cytolytic effects of Newcastle disease virus strain AF2240 on DBTRG. 05mg brain tumor cell line. Int J Cancer Res 2011, 7. 25-23.
20. Rola A., Aied A.M., Ali A.M., Ideris A., Omar A.R., Yousoff K., Saif-Ali R. Cytolytic effects and apoptosis induction of Newcastle disease virus strain AF2240 on anaplastic astrocytoma brain tumor cell line. Neurochem Res 2011, 36:2051-2062.
21. Mustafa Z., Roslan H., Abdullah J.M. Targeted therapy for gliomas: the oncolytic virus applications. Brain tumors - current and emerging therapeutic strategies 2011, InTech. A.L. Abujamra (Ed.).
22. Alexander D.J. Newcastle disease. Newcastle disease virus: an avian paramyxovirus 1988, Kluwer Academic Publishers, Netherlands, p. 1-22.
23. Chambers P., Samson A.C.R. A new structural protein for Newcastle disease virus. J Gen Virol 1980, 50:155-166.
24. Yusoff K., Tan W.S., Lau C.H., Ng B.K., Ibrahim L. Sequence of the haemagglutinin-neuraminidase gene of the Newcastle disease virus oral vaccine strain V4-UPM. Avian Pathol 1996, 25:837-844.
25. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
26. Mishell B.B., Shiiqi S.M., Henry C. Selected methods. Cellular immunology 1980, 21-22. Freeman, San Francisco, CA, USA. B.B. Mishell, S.M. Shiiqi (Eds.).
27. Guan T., Qin F., Du J., Geng L., Zhang Y., Li M. AICAR inhibits proliferation and induced S-phase arrest, and promotes apoptosis in CaSki cells. Acta Pharmacol Sin 2007, 28:1984-1990.
28. He Q., Na X. The effects and mechanisms of a novel 2-aminosteroid on murine WEHI-3B leukemia cells in vitro and in vivo. Leuk Res 2001, 25:455-461.
29. Liu J., Li Y., Tang L.J., Zhang G.P., Hu W.X. Treatment of lycorine on SCID mice model with human APL cells. Biomed Pharmacother 2007, 61:229-234.
30. Schirrmacher V., Haas C., Bonifer R., Ahlert T., Gerhards R., Ertel C. Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus. Gene Ther 1999, 6:63-73.
31. Schirrmacher V., Ahlert T., Probstle T., Steiner H.H., Herold-Mende C., Gerhand R., et al. Immunization with virus-modified tumor cells. Semin Oncol 1998, 25:677-696.
32. Cruchten S.V., Broeck W.V. Morphological and biochemical aspects of apoptosis, oncosis and necrosis. Anat Histol Embryol 2002, 31:214-223.
33. Fabian Z., Torocsik B., Kiss K., Csatary L.K., Bodey B., Tigyi J., et al. Induction of apoptosis by a Newcastle disease virus vaccine (MTH-68/H) in PC12 rat phaeochromocytoma cells. Anticancer Res 2001, 21:125-135.
34. Cohen G.M., Sun X.M., Snowden R.T., Dinsdale D., Skilleter D.N. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem J 1992, 286:331-334.
35. Oberhammer F., Wilson J.W., Dive C., Morris I.D., Hickman J.A., Wakeling A.E., Walker P.R., Sikorska M. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 1993, 12:3679-3684.
36. Gooch J.L., Yee D. Strain-specific differences in formation of apoptotic DNA ladders in MCF-7 breast cancer cells. Cancer Lett 1999, 144:31-37.
37. Wietrzyk J., Chodynski M., Fitak H., Wojdat E., Kutner A., Opolski A. Antitumor properties of diastereomeric and geometric analogs of vitamin D3. Anticancer Drugs 2007, 18:447-457.
38. Lin J.P, Yang J.S., Lu C.C., Chiang J.H., Wu C.L., Lin J.J., et al. Rutin inhibits the proliferation of murine leukemia WEHI-3 cells in vivo and promotes immune response in vivo. Leuk Res 2009, 33:823-828.
39. Tsou M.F., Peng C.T., Shih M.C., Yang J.S., Lu C.C., Chiang J.H., et al. Benzyl isothiocyanate inhibits murine WEHI-3 leukemia cells in vitro and promotes phagocytosis in BALB/c mice in vivo. Leuk Res 2009, 33:1505-1511.